Medicare Enrolled
Dr. Priyadarshan Bajpayi, M.D.
Child & Adolescent Psychiatry Physician · Massapequa, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bajpayi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bajpayi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bajpayi
Dr. Priyadarshan Bajpayi is a child & adolescent psychiatry physician in Massapequa, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Bajpayi performed 8,659 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bajpayi received a total of $217,759 from 43 pharmaceutical and/or device companies across 1742 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bajpayi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 1% volume in NY
$217,759 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,659
Medicare services
Top 1% in NY for child & adolescent psychiatry physician
Not available
Unique patients (not deduplicated)
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,989 | $92 | $218 |
| 45-minute psychotherapy and evaluation visit A 45-minute session that includes both psychotherapy and an evaluation and management visit. |
2,359 | $69 | $216 |
| Psychotherapy and evaluation, 30 minutes A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes. |
1,175 | $54 | $185 |
| Psychotherapy session, 1 hour A one-hour psychotherapy session involving talk therapy to address mental health concerns. |
758 | $120 | $261 |
| Magnetic field treatment to stimulate brain nerve cells A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment. |
304 | $172 | $325 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
280 | $68 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
260 | $133 | $232 |
| Psychiatric diagnostic evaluation with medical services A psychiatric assessment that includes medical services to evaluate mental health conditions. |
215 | $164 | $399 |
| Psychological test evaluation, first hour A healthcare professional evaluates the results of psychological testing during an initial one-hour session. |
98 | $104 | $198 |
| Psychotherapy session, 45 min A 45-minute session of psychotherapy involving talk therapy to address emotional, behavioral, or mental health concerns. |
73 | $77 | $216 |
| Psychotherapy, 30 minutes A 30-minute session of psychotherapy involving talk therapy to address mental health concerns. |
61 | $58 | $183 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $33 | $152 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
42 | $12 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$217,759
Total received (2018-2024)
Avg $31,108/year across 7 years
Top 1% in NY for child & adolescent psychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
1,742
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$64,660
2023
$66,962
2022
$52,060
2021
$23,333
2020
$5,693
2019
$2,881
2018
$2,169
Payments by company (2024)
Alkermes, Inc.
$20,196
Supernus Pharmaceuticals, Inc.
$14,003
Axsome Therapeutics, Inc.
$12,405
Janssen Pharmaceuticals, Inc
$8,677
Otsuka America Pharmaceutical, Inc.
$6,057
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$554
Teva Pharmaceuticals USA, Inc.
$462
ABBVIE INC.
$401
Lundbeck LLC
$372
E.R. Squibb & Sons, L.L.C.
$358
Corium, LLC
$225
Neurocrine Biosciences, Inc.
$174
Vertical Pharmaceuticals, LLC
$132
HARMONY BIOSCIENCES LLC
$106
Indivior Inc.
$99
Tris Pharma Inc
$67
Bausch Health US, LLC
$55
Avion Pharmaceuticals
$52
Takeda Pharmaceuticals U.S.A., Inc.
$49
Braeburn Inc.
$39
Neuronetics, Inc.
$38
Vanda Pharmaceuticals Inc.
$36
Biogen, Inc.
$35
Almatica Pharma LLC
$35
IRONSHORE PHARMACEUTICALS INC.
$18
Neos Therapeutics, LP
$14
Top 3 companies account for 72.1% of 2024 payments
All-time payments by company (2018-2024) ›
Alkermes, Inc.
$78,808
Otsuka America Pharmaceutical, Inc.
$38,597
Axsome Therapeutics, Inc.
$24,142
Janssen Pharmaceuticals, Inc
$18,676
Supernus Pharmaceuticals, Inc.
$14,493
ABBVIE INC.
$12,854
AbbVie Inc.
$7,999
Tris Pharma Inc
$4,271
Lundbeck LLC
$3,639
Takeda Pharmaceuticals U.S.A., Inc.
$1,969
Sunovion Pharmaceuticals Inc.
$1,931
Teva Pharmaceuticals USA, Inc.
$1,434
Ironshore Pharmaceuticals Inc.
$1,129
ITI, Inc.
$1,080
Neos Therapeutics, LP
$950
Bausch Health US, LLC
$648
Corium, LLC
$612
Neurocrine Biosciences, Inc.
$565
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$554
Indivior Inc.
$456
E.R. Squibb & Sons, L.L.C.
$358
Shire North American Group Inc
$312
IDORSIA PHARMACEUTICALS US INC
$283
ARBOR PHARMACEUTICALS, INC.
$279
Allergan, Inc.
$251
Adlon Therapeutics L.P.
$231
Orexo US, Inc.
$227
Almatica Pharma LLC
$179
Vertical Pharmaceuticals, LLC
$132
HARMONY BIOSCIENCES LLC
$106
Avion Pharmaceuticals
$93
Neuronetics, Inc.
$80
Brainsway USA INC
$63
Alfasigma USA, Inc.
$59
JAZZ PHARMACEUTICALS INC.
$56
OWP Pharmaceuticals, Inc.
$47
Braeburn Inc.
$39
Vanda Pharmaceuticals Inc.
$36
Biogen, Inc.
$35
Eisai Inc.
$29
Arbor Pharmaceuticals, Inc.
$27
IRONSHORE PHARMACEUTICALS INC.
$18
Kaleo, Inc.
$11
Top 3 companies account for 65.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adlarity · Adzenys XR-ODT · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BRINTELLIX · BRIXADI · BrainsWay Deep TMS · Brainsway Deep TMS · CAPLYTA · CITALOPRAM · COBENFY · COTEMPLA XR-ODT · Dayvigo · Dhivy · Dyanavel XR · EVZIO · Evekeo · Evekeo ODT · GRALISE · HETLIOZ · Horizant · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · MYDAYIS · Methylphenidate Hydrochloride · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · OXTELLAR XR · PERSERIS · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · REXULTI · Relexxii · SPRAVATO · SUBLOCADE · SUNOSI · Subvenite · Sunosi · TAKHZYRO · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VIVITROL · VRAYLAR · VYVANSE · Vivitrol · Vivitrol 380 mg · WAKIX · ZURZUVAE · Zubsolv
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Child & adolescent psychiatry physicians in nearby ZIP areas
148
County median income
$143,408
Nearest hospital to ZIP centroid (approximate)
BRUNSWICK HOSPITAL CENTER, INC.
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bajpayi is a clinical cardiology specialist, with above-average Medicare volume (top 1% in NY), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bajpayi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bajpayi performed 2,989 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bajpayi receive payments from pharmaceutical companies?
Yes. Dr. Bajpayi received a total of $217,759 from 43 companies across 1,742 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bajpayi's costs compare to other child & adolescent psychiatry physicians in Massapequa?
Dr. Bajpayi's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bajpayi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Child & Adolescent Psychiatry Physicians in Massapequa
Browse child & adolescent psychiatry physicians in Massapequa ranked by procedure volume and transparency data.
Highest volume
Top Child & Adolescent Psychiatry Physicians in NY
Child & adolescent psychiatry physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Child & Adolescent Psychiatry Physicians in NY
Which NY child & adolescent psychiatry physicians receive the most from drug and device companies.
By company
Alkermes, Inc. Payments to Doctors
See all physicians who received payments from Alkermes, Inc.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Axsome Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Axsome Therapeutics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology